These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2725417)

  • 21. [Safety criteria in working with metallic beryllium].
    Petrin SV; Petrina LS; Pinaev VS
    Gig Sanit; 2004; (2):28-31. PubMed ID: 15141624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic beryllium disease: risk from low-level exposure.
    Redlich CA; Welch LS
    Am J Respir Crit Care Med; 2008 May; 177(9):936-7. PubMed ID: 18434330
    [No Abstract]   [Full Text] [Related]  

  • 23. [Beryllium--underestimated occupational health hazard in Poland].
    Dudek W; Walusiak J; Wittczak T
    Med Pr; 2001; 52(6):471-8. PubMed ID: 11928678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Berylliosis in the work environment: etiology and medical treatment].
    Sieradzki A; Andrzejak R; Sieradzka U
    Med Pr; 2002; 53(2):151-60. PubMed ID: 12116906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. To Be2+ or not to Be2+: immunogenetics and occupational exposure.
    Newman LS
    Science; 1993 Oct; 262(5131):197-8. PubMed ID: 8105535
    [No Abstract]   [Full Text] [Related]  

  • 26. Beryllium: epidemiological evidence.
    Saracci R
    IARC Sci Publ; 1985; (65):203-19. PubMed ID: 4086084
    [No Abstract]   [Full Text] [Related]  

  • 27. Solubility and chemistry of materials encountered by beryllium mine and ore extraction workers: relation to risk.
    Deubner DC; Sabey P; Huang W; Fernandez D; Rudd A; Johnson WP; Storrs J; Larson R
    J Occup Environ Med; 2011 Oct; 53(10):1187-93. PubMed ID: 21926919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assessment of occupational exposure to beryllium and its compounds].
    Gaweda E; Madej M
    Med Pr; 2000; 51(3):221-8. PubMed ID: 11002468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant.
    Newman LS; Mroz MM; Maier LA; Daniloff EM; Balkissoon R
    J Occup Environ Med; 2001 Mar; 43(3):231-7. PubMed ID: 11285871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beryllium disease and sarcoidosis: clinical and laboratory links.
    Newman LS
    Sarcoidosis; 1995 Mar; 12(1):7-19. PubMed ID: 7617981
    [No Abstract]   [Full Text] [Related]  

  • 31. Mortality patterns from lung cancer and nonneoplastic respiratory disease among white males in the beryllium case registry.
    Infante PF; Wagoner JK; Sprince NL
    Environ Res; 1980 Feb; 21(1):35-43. PubMed ID: 7389704
    [No Abstract]   [Full Text] [Related]  

  • 32. Beryllium disease among workers in a spacecraft-manufacturing plant--California.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1983 Aug; 32(32):419-20, 425. PubMed ID: 6410175
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible health risks from low level exposure to beryllium.
    Stange AW; Hilmas DE; Furman FJ
    Toxicology; 1996 Jul; 111(1-3):213-24. PubMed ID: 8711738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Characteristics of the combined action of the beryllium-containing dust from complex metal ores in the Far North (clinical hygienic and experimental studies)].
    Lutaĭ AV; Kazantseva SV; Fed'kina LG; Lutaĭ GF; Solomina SN
    Gig Tr Prof Zabol; 1979 Sep; (9):15-9. PubMed ID: 535747
    [No Abstract]   [Full Text] [Related]  

  • 35. The pulmonary toxicity of beryllium.
    Kriebel D; Brain JD; Sprince NL; Kazemi H
    Am Rev Respir Dis; 1988 Feb; 137(2):464-73. PubMed ID: 3277503
    [No Abstract]   [Full Text] [Related]  

  • 36. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease.
    Fontenot AP; Maier LA
    Trends Immunol; 2005 Oct; 26(10):543-9. PubMed ID: 16099719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental pulmonary berylliosis in rabbits sensitized to beryllium sulfate: contact hypersensitivity.
    Eskenasy A
    Morphol Embryol (Bucur); 1979; 25(3):257-62. PubMed ID: 159411
    [No Abstract]   [Full Text] [Related]  

  • 39. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.
    Kreiss K; Mroz MM; Zhen B; Wiedemann H; Barna B
    Occup Environ Med; 1997 Aug; 54(8):605-12. PubMed ID: 9326165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comments on the choice of exposure metrics as risk indicators.
    Wambach PF
    J Occup Environ Hyg; 2007 Oct; 4(10):D103-4; author reply D104-8. PubMed ID: 17763067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.